Our Pricing

Promethazine BNF Information: Your Complete Guide

Searching for a reliable promethazine BNF dosage guide UK? This comprehensive resource provides pharmacist-verified information on promethazine hydrochloride, including BNF-referenced dosing schedules, clinical indications, and safety considerations. At Cured Pharmacy, our UK-registered clinical team ensures you receive expert guidance alongside genuine licensed medications from £17.54.

What Is Promethazine? BNF Classification and Mechanism

Promethazine hydrochloride is a first-generation antihistamine classified in the BNF under section 3.4.1 (Antihistamines) and section 4.6 (Drugs used in nausea and vertigo) [1]. Unlike newer non-sedating antihistamines, promethazine crosses the blood-brain barrier, producing both peripheral antihistamine effects and central nervous system depression.

The medication works by competitively blocking histamine H1 receptors, preventing histamine-mediated allergic responses including urticaria, rhinitis, and pruritus [1]. Its anticholinergic properties also contribute to antiemetic effects, making it effective for motion sickness and nausea associated with various conditions. Clinical studies demonstrate promethazine's sedative effects typically begin within 20 minutes of oral administration and persist for 4-6 hours [2].

Promethazine is available in multiple formulations at Cured Pharmacy, including 25mg tablets and elixir preparations, allowing flexible dosing for different age groups and clinical scenarios. All promethazine products are prescription-only medications in the UK and require clinical assessment by a registered prescriber before dispensing.

BNF-Referenced Promethazine Dosage Guidelines

Adult Dosing for Allergic Conditions

For symptomatic relief of allergic conditions, the BNF recommends 25mg promethazine at night, or 10-20mg taken two to three times daily [1]. Some patients may require up to 25mg three times daily, though this should only be prescribed following clinical assessment. Our superintendent pharmacist Tarun Kumar notes that evening administration often provides optimal symptom control whilst minimising daytime sedation impact.

When used for motion sickness prevention, the BNF advises taking 20-25mg promethazine the night before travel, followed by a repeat dose 1-2 hours before departure if needed [1]. For ongoing journeys, doses may be repeated every 6-8 hours, subject to prescriber approval and maximum daily dose considerations.

Promethazine for Sleep: BNF Guidance on Short-Term Use

The BNF lists promethazine under section 4.1.1 (Hypnotics) for short-term management of insomnia in adults [1]. The recommended dose is 25mg taken 30-60 minutes before bedtime, though some patients may require up to 50mg following clinical assessment. Importantly, the BNF emphasises that hypnotic use should be restricted to short courses of no more than 1-2 weeks.

Clinical evidence demonstrates promethazine reduces sleep latency and increases total sleep duration in patients with transient insomnia [3]. However, tolerance to sedative effects can develop within 7-14 days of continuous use, reducing efficacy. The MHRA advises against long-term hypnotic use due to dependency risks and next-day cognitive impairment [4].

Phenergan Night Tablets 25mg, available from Cured Pharmacy at £17.54, are specifically formulated for sleep disturbance. Our UK prescribers assess each patient's sleep history, underlying causes, and contraindications before approving treatment, ensuring safe and appropriate use aligned with BNF recommendations.

Paediatric Dosing and Age Restrictions

BNF for Children Dosage Recommendations

Promethazine is contraindicated in children under 2 years due to fatal respiratory depression risk [1][4]. For children aged 2-5 years, the BNF for Children recommends 5-15mg daily in divided doses for allergic conditions, typically administered via elixir formulation for accurate dosing. Children aged 5-10 years may receive 5-15mg twice daily, whilst those over 10 years can take adult doses subject to prescriber assessment.

The MHRA issued specific warnings in 2019 regarding over-the-counter promethazine use in children, restricting pharmacy sales to those aged 6 years and above [4]. Prescription supply for younger children (2-6 years) remains available following specialist assessment, though alternative non-sedating antihistamines are often preferred first-line.

Common Side Effects and BNF Safety Information

The BNF lists promethazine's most common side effects as drowsiness, dizziness, dry mouth, blurred vision, and urinary retention [1]. These anticholinergic effects occur in approximately 20-40% of patients in clinical studies, though severity varies considerably [2]. Patients should be advised to avoid driving or operating machinery until they know how promethazine affects them, as sedation can impair psychomotor performance for up to 12 hours.

Less common but clinically significant adverse effects include paradoxical stimulation (particularly in children and elderly patients), photosensitivity reactions, and blood dyscrasias [1]. The BNF advises patients to report any unexplained bruising, bleeding, or persistent sore throat, as these may indicate haematological complications requiring immediate medical attention.

Antimuscarinic side effects can be particularly problematic in elderly patients, potentially precipitating urinary retention in men with prostatic hypertrophy or acute confusion in those with cognitive impairment [1]. Our clinical team at Cured Pharmacy carefully screens for these risk factors during online consultations, ensuring promethazine is only prescribed when benefits clearly outweigh potential harms.

Contraindications and Drug Interactions per BNF

Important Prescribing Considerations

The BNF lists absolute contraindications including hypersensitivity to phenothiazines, concurrent MAO inhibitor use, and children under 2 years [1]. Relative contraindications requiring careful risk-benefit assessment include severe coronary artery disease, epilepsy, prostatic hypertrophy, angle-closure glaucoma, and hepatic impairment.

Promethazine potentiates central nervous system depressants including alcohol, benzodiazepines, opioids, and other sedating antihistamines [1]. Concurrent use with medications possessing antimuscarinic properties (tricyclic antidepressants, antiparkinson drugs, antispasmodics) can produce additive anticholinergic effects, increasing risks of confusion, constipation, and urinary retention. Our UK prescribers review full medication histories during consultations to identify potential interactions before approving treatment.

Scientific References

1. Joint Formulary Committee. (2024). British National Formulary (BNF) 87. BMJ Group and Pharmaceutical Press. https://bnf.nice.org.uk/
2. Simons, F. E. R., & Simons, K. J. (2011). Histamine and H1-antihistamines: celebrating a century of progress. Journal of Allergy and Clinical Immunology, 128(6), 1139–1150. https://doi.org/10.1016/j.jaci.2011.09.005
3. Rickels, K., Morris, R. J., Newman, H., Rosenfeld, H., Schiller, H., & Weinstock, R. (1983). Diphenhydramine in insomniac family practice patients: a double-blind study. Journal of Clinical Pharmacology, 23(5-6), 234–242. https://doi.org/10.1002/j.1552-4604.1983.tb02727.x
4. Medicines and Healthcare products Regulatory Agency. (2019). Over-the-counter cough and cold medicines for children: updated restrictions for use. Drug Safety Update, 12(8), 3. https://www.gov.uk/drug-safety-update/

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.